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Abstract
Evidence is rapidly growing regarding a role of astroglial cells in the pathogenesis of Alzheimer’s disease (AD), and the
hippocampus is one of the important brain regions affected in AD. While primary astroglial cultures, both from wild-
type mice and from rodent models of AD, have been useful for studying astrocyte-specific alterations, the limited cell
number and short primary culture lifetime have limited the use of primary hippocampal astrocytes. To overcome these
limitations, we have now established immortalized astroglial cell lines from the hippocampus of 3xTg-AD and wild-
type control mice (3Tg-iAstro and WT-iAstro, respectively). Both 3Tg-iAstro and WT-iAstro maintain an astroglial
phenotype and markers (glutamine synthetase, aldehyde dehydrogenase 1 family member L1 and aquaporin-4) but
display proliferative potential until at least passage 25. Furthermore, these cell lines maintain the potassium inward
rectifying (Kir) current and present transcriptional and proteomic profiles compatible with primary astrocytes.
Importantly, differences between the 3Tg-iAstro and WT-iAstro cell lines in terms of calcium signaling and in terms of
transcriptional changes can be re-conducted to the changes previously reported in primary astroglial cells. To illustrate
the versatility of this model we performed shotgun mass spectrometry proteomic analysis and found that proteins
related to RNA binding and ribosome are differentially expressed in 3Tg-iAstro vs WT-iAstro. In summary, we present
here immortalized hippocampal astrocytes from WT and 3xTg-AD mice that might be a useful model to speed up
research on the role of astrocytes in AD.
Introduction
While in Alzheimer’s disease (AD) astrocytes have been
historically associated with reactive gliosis and
neuroinflammation, a growing body of evidence suggests
that astroglial alterations occur in the early stages of AD,
compromising their housekeeping and homeostatic
functions that in turn may result in synaptic and neuronal
malfunction1,2.
Most of the information about the role of astrocytes in
brain pathology has been collected in in vitro experiments
on primary cultures. Easy to prepare and handle, astroglial
primary cultures are made from different brain areas3,4
and different animal species5–8. However, primary cul-
tures present several limitations such as inter-culture
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variability, short culture lifetime and limited number of
cells if cultures are prepared from specific brain areas,
such as the hippocampus. To overcome these limitations,
immortalized astroglial lines have been proposed. The
first attempts to generate a permanent astroglial cell line,
not deriving from brain tumors, date back to early eigh-
ties9. Since then, a number of immortalized astroglial lines
have been established10–23. Most of them derive from a
highly heterogeneous population of cortical primary
astrocytes; however, immortalization of astrocytes from
brain regions other than cortex have also been reported,
e.g., from the cerebellum9 or from the midbrain21. Sur-
prisingly, few attempts have been reported to immortalize
astrocytes from hippocampus and also from animal
models of AD. In this regard, Morikawa et al.18 have
generated immortalized astrocytes from ApoE2, ApoE3
and ApoE4 knock-in mice.
In this report we introduce immortalized astroglial lines
from the hippocampus of a well-characterized AD mouse
model, 3xTg-AD, and from wild-type (WT) control mice,
from now on referred to as 3Tg-iAstro and WT-iAstro,
respectively. WT-iAstro cell lines show features of pri-
mary hippocampal astrocytes such as basic electro-
physiological properties, and a similar transcriptional and
proteomic profile. More importantly, 3Tg-iAstro show
alterations in transcription and deregulation of Ca2+ sig-
naling as it was reported for its primary counterparts. To
illustrate the versatility of this model we also performed
shotgun mass spectrometry proteomic analysis and found
that proteins related to RNA binding and ribosome are
differentially expressed in 3Tg-iAstro vs WT-iAstro.
These data demonstrate that iAstro lines represent a
versatile and useful cellular model to investigate astroglial
AD-related pathobiology.
Results
Generation of immortalized hippocampal astrocytes
(iAstro) from WT and 3xTg-AD mice
Six immortalized cell lines from WT (WT-iAstro#1–6)
and from 3xTg-AD (3Tg-iAstro#1–6) mice were gener-
ated, from separate primary astrocyte cell cultures. For
immortalization, primary astroglial cultures were first
depleted of microglial cells by magnetic-assisted cell
sorting (MACS) using anti-CD11b-conjugated microbe-
ads in order to obtain a population of highly purified
astrocytes. Astrocytes were then transduced using retro-
virus expressing SV40 large T antigen. Transformed cells
were selected in G418, amplified and stabilized for 12
passages prior to characterization. No clonal selection was
performed to maintain the natural hererogeneity of the
cultures.
For logistic and experimental setting convenience, four
lines for each strain were characterized for morphology
and astroglial marker expression. The other two cell lines
were confirmed for morphological identity to other lines,
but were maintained as backups and have not been
characterized (#1 and #5 for WT-iAstro and #1 and #4 for
3Tg-iAstro lines).
iAstro cells show a morphology similar and virtually
indistinguishable to those of primary hippocampal astro-
cytes in bright field microscopy (Fig. 1a). We also eval-
uated the expression of the astroglial markers aquaporin-4
(AQP4), glutamine synthetase (GS) and aldehyde dehy-
drogenase 1 family member l1 (Aldh1l1) (Fig. 1b) by
immunocytochemistry. Importantly, we found expression
of all three markers in all cell lines. Immunocytochemical
analysis for glial fibrillary acidic protein (GFAP) showed,
instead, that only a small proportion of cells were positive
in the established immortalized cell lines (15.4 ± 5.3 % in
WT-iAstro vs 16.7 ± 5.9 % in 3Tg-iAstro cells, p > 0.05)
(Fig. 1c), while 100% of cells were GFAP positive in WT-
and 3Tg-primary astrocytes.
We also decided to have a quantitative measure of the
expression of the three markers by evaluating protein
levels in western blotting on three of the four cell lines.
The three markers were mostly decreased compared to
primary cell lines, albeit at different levels. AQP4 was the
least decreased, while Aldh1l1 was the most decreased,
with qualitative consistency in the immortalized cell lines
tested. Importantly, not only were all the markers
detectable, but they were also represented at similar levels
between the WT- and 3Tg-iAstro cell lines (Fig. 2).
We also evaluated the ability of the iAstro cell lines to
be passaged in culture. iAstro lines did not change their
morphology or marker expression significantly at least up
to 20th passage (not shown).
Kir currents are present but are not different in WT-iAstro
and 3Tg-iAstro
Maintenance of ionic balance is one of the house-
keeping functions of astrocytes and a feature which might
have been lost during immortalization. Potassium buf-
fering by inwardly rectifying K+ (Kir) channels during
neuronal activity is fundamental to maintain adequate
synaptic transmission and neuronal excitability24. We
have previously shown that Kir channels are functionally
expressed in primary hippocampal astrocytes25. There-
fore, we performed patch-clamp experiments in WT-
iAstro#2 and 3Tg-iAstro#2 lines. To confirm that Kir
function was not affected by the immortalization process,
control hippocampal mouse astrocytes were also patched
in order to record Kir current. Cells were exposed to a
step protocol of increasing voltage (20 mV increments)
from −180 mV to +60 mV to record current elicited by
Kir channels. Before each voltage step increment, cells
were kept at 0 mV for 300ms in order to block outward
potassium flow26. Application of this protocol triggered
Kir current in the cell lines tested (Fig. 3a). Current (I),
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measured at each step of recording protocol, was plotted
over corresponding applied voltage (V) to determine I/V
curve for Kir channels in both cell lines. Raw current
values were normalized to maximum I obtained at +60
mV for each cell (Fig. 3b). No differences were found in
iAstro Kir currents through at least five passages. No
significant differences were observed in Kir
currents between control primary astrocytes and WT-
and 3Tg-iAstro lines.
iAstro cells are capable of glutamate uptake
Another fundamental function of astrocytes in the reg-
ulation of synaptic transmission is the uptake of glutamate
through the action of sodium-dependent glutamate trans-
porters27. In the hippocampus, GLT-1 (excitatory amino
acid transporter 2 (EAAT2)) is the major glutamate trans-
porter28. Therefore, we investigated the expression of GLT-
1 and glutamate uptake in iAstro lines. As shown in Sup-
plementary Figure 1A, anti-GLT-1 staining revealed
Fig. 1 Characterization of WT- and 3Tg-iAstro lines. a Phase contrast images of four WT-iAstro and four 3Tg-iAstro lines at passage 15. Bar, 100
μm. b Immunofluorescence images of WT-iAstro#2 and 3Tg-iAstro#2, stained with anti-AQP4, anti-GS, anti-Aldh1l1 and anti-GFAP antibodies. Bar, 50
μm. The images shown in (a, b) are representative of n= 3 independent experiments. c Quantification of GFAP-positive cells in WT-iAstro#2 and 3Tg-
iAstro#2 lines. Data expressed as mean ± SD % of 15 fields of GFAP-positive cells evaluating a total of 359 WT- and 514 3Tg-iAstro cells. In (b, c), other
characterized independently generated iAstro lines show similar results in immunostaining of astroglial markers and in quantification of GFAP-
positive cells (data not shown)
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membrane-localized expression of GLT-1 in both primary
astrocytes and in iAstro lines. Supplementary Figure 1B
shows that WT-iAstro cells are capable of glutamate uptake
from the medium with a rate (10.73 ± 1.19 μmol/g protein,
n= 3) comparable to that of primary astrocytes (19.38 ±
3.74 μmol/g protein, n= 3; p= 0.092). No differences were
found in glutamate uptake between WT-iAstro and 3Tg-
iAstro lines (10.77 ± 2.14 μmol/g protein, n= 3; p= 0.12).
ATP-induced Ca2+ signaling is altered in immortalized
hippocampal astrocytes from 3xTg-AD mice
Astrocytes respond to external stimuli primarily by
generating intracellular Ca2+ signals, employing a
combination of release of Ca2+ from the internal stores
via metabotropic mechanisms and Ca2+ entry from the
extracellular space through the plasma membrane via
store-operated Ca2+ entry29–31. We have previously
shown that astrocytic Ca2+signaling in AD is altered using
a variety of protocols/models usually employed for neu-
ronal evaluation, including Aβ oligomer treatment32, an
uncoupling peptide of ADAM10 and SAP9733, or triple
transgenic mice34. Astrocytic Ca2+ signaling has been
shown to be altered in AD also by others in vivo and
in vitro35–38.
To validate our immortalized cell lines, we therefore
decided to investigate astrocytic Ca2+ signaling using
Fig. 2 Western blot analysis and quantification of astroglial marker proteins Aqp4, GS, Aldh1l1 and GFAP. Western blot analysis (a) was
performed from four independently generated iAstro lines for each genotype (WT-iAstro#2, #3, #5 and #6, and 3Tg-iAstro#2, #3, #4 and #6). Each
point represents mean ± SEM of 3 independent experiments. Actin was used as loading control. ANOVA followed by Tukey’s post-hoc test was used
for statistical analysis. For Aqp4 (b) and GS (c) there were no significant differences. For Aldh1l1 (d) and GFAP (e) the differences were significant for
iAstro lines vs primary astrocytes: **p < 0.01; ***p < 0.001; ****p < 0.0001
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Fura-2 single cell Ca2+ imaging. In pilot experiments, 4
WT lines (WT-iAstro#2, #3, #5 and #6) and 4 3Tg-iAstro
lines (3Tg-iAstro#2, #3, #4 and #6) were tested for ade-
nosine triphosphate (ATP; 20 μM)-induced Ca2+
responses, which is among the signaling pathways found
altered in AD34. As no significant differences were
observed between lines of the same genotype (data not
shown), WT-iAstro#2 and 3Tg-iAstro#2 were chosen for
further analysis. Traces and histograms in Fig. 4a repre-
sent mean ± SEM of 195 cells from WT-iAstro (1.39 ±
0.035 norm. Fura ratio) and 192 cells from 3Tg-iAstro
lines (1.69 ± 0.045 norm. Fura ratio) and show that 3Tg-
iAstro exhibited significantly higher amplitude of Ca2+
responses (p= 0.0006). As it can be observed, application
of ATP to iAstro produces a long-lasting “after-peak”
shoulder which is significantly higher in 3Tg-iAstro than
in WT-iAstro (48.58 ± 1.86 area under the curve (AUC) of
norm. Fura ratio for WT-iAstro vs 60.83 ± 1.71 for 3Tg-
iAstro, p= 0.00005) (Fig. 4c). Given that in primary
astrocytes we had observed a similar effect with
mGluR5 stimulation that was mediated by store-operated
Ca2+ entry (SOCE)39, we decided to further explore the
effect of ATP. Applications of ATP (20 μM) in Ca2+-free
solution or pre-treatment with the SOCE inhibitor Pyr3
(10 μM) completely eliminated the shoulder in both WT-
iAstro and 3Tg-iAstro, while the amplitudes of the
responses were higher in 3Tg-iAstro cells compared to
WT-iAstros (1.31 ± 0.039 norm. Fura ratio, n= 115, for
3Tg-iAstro vs 1.19 ± 0.03, n= 118, for WT-iAstro, p=
0.040 in Ca2+-free solution; 1.05 ± 0.025 norm. Fura ratio,
n= 161, for 3Tg-iAstro vs 0.89 ± 0.018, n= 155, for WT-
iAstro, p= 0.000001 in Pyr3-treated cells) (Fig. 4b). This
suggests that ATP, similarly to (RS)-3,5-Dihydrox-
yphenylglycine (DHPG, an agonist of group I metabo-
tropic glutamate receptors), induced SOCE-mediated
Ca2+ entry through the plasma membrane. This was
confirmed by re-addition of Ca2+ after depletion of the
endoplasmic reticulum Ca2+ stores with a SERCA inhi-
bitor (tBHQ, 20 μM, 5min) in a Ca2+-free Krebs-Ringer
modified buffer (KRB) solution (71.5 ± 1.64 AUC of norm.
Fura ratio, n= 66, for 3Tg-iAstro vs 58.51 ± 1.94, n= 71,
for WT-iAstro, p= 0.00011) (Fig. 4c).
In the current experimental setting the astroglial Ca2+
signals are likely to be mediated by two types of purinergic
receptors, P2Y1 and P2Y2. Relative quantification of
messenger RNA (mRNA) of P2ry1 and P2ry2 in WT and
3Tg-iAstro lines using real-time PCR showed a higher
levels of P2ry2 mRNA compared with P2ry1; moreover,
P2ry2 was significantly more expressed in 3Tg-iAstro
compared with WT, while levels of P2ry1 were not dif-
ferent. These data suggest that P2Y2 but not P2Y1 may
mediate enhanced sensitivity of 3Tg-iAstro to ATP
(Fig. 4d).
Surprisingly, and contrary to our previous observations
on primary astrocytes34, we found that iAstro cell lines did
not respond to DHPG.
iAstro lines maintain gene expression differences found
previously between WT and 3xTg-AD primary astrocytes
We recently performed a whole-genome microarray
analysis of purified primary hippocampal astrocytes40 in
which bioinformatic analysis revealed expression differ-
ences between astrocytes prepared from WT and from
3Tg animals. To further characterize our immortalized
cell lines we therefore primed 14 of the identified genes
that showed modifications (Car9, P2ry2, Padi2, Col2a1,
Col4a6, Fbln2, Cacna2d3, Panx1, Pcdh17, Trim12, Ccl27a
PESKY, Ptchd2, Slc2a4 and Samd4). This set was com-
posed of 6 genes (Pcdh17, Col2a1, Col4a6, Fbln2, Cac-
na2d3, Panx1) involved in cell adhesion (a gene ontology
cluster that was found over-represented), two down-
regulated genes (Padi2 and Samd4) and a set of 6
up-regulated genes (Trim12, Ptchd2, Slc2a4, Ccl27a
PESKY, Car9 and P2ry2).
Fig. 3 Kir are functional in both WT- and 3Tg-iAstro lines. a
Representative Kir currents elicited in WT-iAstro#2 and 3Tg-iAstro#2
astrocytes in basal conditions. Inset shows the voltage step protocol
applied (from −180mV to +60 mV for 100 ms in 20 mV increments).
Voltage at 0 mV is shown (dotted line). b Current/voltage relationship
(I/V curve) elicited in WT-primary (black dotted line), WT-iAstro#2 (gray
line) and 3Tg-iAstro#2 (black line) astrocytes. Raw current (I) values
were normalized to maximum I obtained at +60 mV for each cell.
Each point is shown as average ± SEM (n= 6)
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Fig. 4 Calcium signaling alterations in 3Tg-iAstro as compared to WT-iAstro lines. a Fura-2-loaded WT- and 3Tg-iAstro cells were stimulated with
20 μM ATP in Ca2+-containing KRB solution. Data are expressed as mean of peak ± SEM or mean of area under the curve (AUC) ± SEM of 195 cells (WT-
iAstro#2; 1.39 ± 0.035 norm. Fura ratio) and 192 cells (3Tg-iAstro#2; 1.69 ± 0.045 norm. Fura ratio, p= 0.0006) from 12 coverslips from 3 independent
experiments. ***p < 0.001. b WT- and 3Tg-iAstro cells were stimulated with 20 μM ATP in Ca2+-free KRB solution (left panel; mean of peak ± SEM of 118
cells (WT-iAstro#2; 1.19 ± 0.03 norm. Fura ratio) and 115 cells (3Tg-iAstro#2; 1.31 ± 0.039 norm. Fura ratio, p= 0,040) or in Ca2+-containing KRB
supplemented with 10 μM Pyr3, a store-operated Ca2+ channel blocker (right panel; mean of peak ± SEM of 155 cells (WT-iAstro#2; 0.89 ± 0.018 norm. Fura
ratio) and 161 cells (3Tg-iAstro#2; 1.05 ± 0.025 norm. Fura ratio, p= 0.000001). c Fura-2-loaded cells were depleted of Ca2+ with 20 μM tBHQ (a SERCA
blocker) in Ca2+-free KRB for 5min after which Ca2+ was re-added and Fura-2 ratio was measured. Data are expressed as mean ± SEM of AUC of 71 WT-
iAstro#2 cells (58.51 ± 1.94 AUC of norm. Fura ratio) and 66 3Tg-iAstro#2 cells (71.5 ± 1.64 AUC of norm. Fura ratio, p= 0.00011) from 8 coverslips from 3
independent experiments. d Real-time PCR of P2ry1 (left graphs) and P2ry2 (right graph) from primary astrocytes and iAstro lines. Values represent
mean ± SD ΔC(t) of gene/S18 of four independent cultures. Unpaired two-tailed Student’s t-test was used for statistical analysis
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First, we compared levels of the genes between primary
WT astrocytes and WT-iAstro, comparing ΔC(t) of a
gene of interest with respect to S18 C(t). Given the low
variability between different primary cultures and
between different iAstro cultures, comparison was made
averaging data fromWT-iAstro #2, #3, #5 and #6 and four
primary cultures. As shown in Fig. 5, most of the genes
were expressed in the same order of magnitude between
primary and immortalized cells, although a few genes
(Car9, Padi2 and Ptchd2) showed a reduced expression of
at least one order of magnitude differences.
Our aim, though, was to validate, independently of the
expression levels, whether the differences in expression
between primary WT and 3Tg astrocytes could be reca-
pitulated in the immortalized cell lines. As shown in
Fig. 6a, all 14 genes followed the changes found previously
in primary astrocytes40. A plot in Fig. 6b shows high
degree of correlation between primary and immortalized
astrocytes. Taken together, these results show that after
the immortalization hippocampal astrocytes retain the
transcriptional changes found in primary 3xTg-AD vs
WT astrocytes for, at least, a selected group of genes.
Immortalized astrocytes up-regulate iNOS in response to
pro-inflammatory stimuli
The role of astrocytes in neuroinflammation is well
ascertained31,41, and therefore we have investigated if
iAstro lines responded to pro-inflammatory stimuli like
bacterial lipopolysaccharide (LPS) or tumor necrosis
factor-α (TNFα). As shown in Supplementary Figure 2,
inducible nitric oxide synthase (iNOS) was induced upon
treatment with both LPS (100 ng/ml for 3 h) and TNFα
treatment (20 ng/ml for 6 h). No differences were found
between WT and 3Tg-primary astrocytes or iAstro lines.
We recently reported that transforming growth factor-
β2 (TGFβ2) and TGFβ3 were up-regulated at mRNA
levels in 3Tg-primary astrocytes as compared to WT
astroglial cultures42. We, therefore, investigated the levels
of mRNA of TGFβ2 and TGFβ3 in both non-stimulated
and LPS-treated iAstro lines. As shown in Supplementary
Figure 3, in line with cultured primary astrocytes42,
TGFβ3 is the most expressed TGFβ isoform in iAstro
lines. Moreover, TGFβ3 was significantly up-regulated in
3Tg-iAstro (0.267 ± 0.02 ΔC(t) TGFβ3/S18, n= 4) com-
pared to WT-iAsro cells (0.094 ± 0.014 ΔC(t) TGFβ3/S18,
n= 4; p= 0.0012) (Supplementary Figure 3B). No differ-
ences were found in TGFβ2 or TGFβ3 mRNA levels upon
treatment with LPS.
Mass spectrometry proteomics revealed alterations in
translation and ribosome in 3Tg-iAstro compared to WT-
iAstro
To further evaluate the iAstro lines, we performed a
shotgun mass spectrometry proteomic analysis using the
four WT and four 3Tg-iAstro lines. In total, 1119 and
1045 proteins were identified, common to the four ana-
lyzed WT- and 3Tg-iAstro lines, respectively (Supple-
mentary Table 1), of which 856 proteins were present in
both WT- and 3Tg-iAstro lines (Fig. 7a).
To demonstrate that WT-iAstro cells retain the astro-
cytic phenotype we compared their proteomic profile with
two published datasets obtained through matrix-assisted
laser desorption/ionization time-of-flight (MALDI-TOF)
mass spectrometry. The first one, provided by Hanrieder
et al.43, featured 130 unambiguous identified proteins
from cultured rat cortical neuroglia. Our dataset included
84 out of 130 (64.6%) of their entries (see Supplementary
Table 2A). Among them, cytochrome C oxidase
(COX5A), cytochrome C (CYC), ubiquitin (RS27A), cha-
peronin 10 (CH10), macrophage inhibitor factor (MIF),
acetyl co-A binding protein (ACBP), thioredoxin (THIO),
calmodulin (CALM), thymosin beta-10 (TYB4) and
ribosomal protein S28 (RS28), reported by Hanrieder
et al.43 as the most astrocyte-specific proteins compared
to both oligodendrocytes and microglia, were notably all
present in our list. Secondly, we compared iAstro proteins
with the proteomic profile provided by Yang et al.44,
consisting of 178 different proteins from mouse cortical
cultured astrocytes. Our list covered 131 out of 178 pro-
teins (73.6%) from the dataset provided by Yang et al.44
(see Fig. 7a and Supplementary Table 2B). Note a rela-
tively small number of detected proteins in Hanrieder
et al.43 and Yang et al.44 datasets compare to our list of
proteins. This may be due to differences in the workflow
of the proteome analysis.
Fig. 5 Comparison of transcriptional levels of selected genes
between primary astrocyte cultures and WT-iAstro cells. The
graph shows log scale of RNA levels for specific genes detected in
primary mouse hippocampal astrocytes (light gray bars) and in four
WT-iAstro lines (#2, #3, #5, #6) (dark gray bars). Data are expressed as
mean ± SD ΔC(t) of gene/S18 of four independent cultures. Unpaired
two-tailed Student’s t-test was used for statistical analysis; #p= 0.17;
§p= 0.00054; *p= 0.0028; £p= 0.012; $p= 0.0019; **p= 0.048; &p=
0.055; @p= 0.064; ##p= 0.013; §§p= 0.091;££p= 0.019; %p= 0.00002;
@@p= 0.021; $$p= 0.19
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Fig. 6 The differences between primary cultured astrocytes from WT and 3xTg mice are retained in the iAstro cell lines. a RT-PCR performed
on samples prepared from WT-iAstro#2, #3, #5, #6 and 3Tg-iAstro#2, #3, #4, #6. Data are expressed as mean ± SD ΔCt of gene/S18 of runs performed
in triplicate. Unpaired two-tailed Student’s t-test was used for statistical analysis. b Correlation plot of differential gene expression between primary
astrocytes and iAstro lines. Abscissa axis shows log2 (fold change) of 3xTg-AD primary cultured hippocampal astrocytes vs WT astrocytes. Ordinate
axis shows log2(fold change) of 3Tg-iAstro vs WT-iAstro lines
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Next, we performed differential gene expression analysis
and identified 73 proteins (p < 0.05; cut-off 30% fold
change) that were significantly changed between WT-
iAstro and 3Tg-iAstro, of which 23 were up-regulated and
50 were down-regulated (Fig. 7b, Table 1 and Supple-
mentary Table 3). Functional classification Gene
Ontology (GO) analysis of all 73 differentially expressed
proteins using DAVID (Database for Annotation, Visua-
lization and Integrated Discovery) online GO tool
returned two groups with significant enrichment score:
the first group (enrichment score 12.8) contained 11
proteins all of which were components of ribosome; the
Fig. 7 Mass spectrometry proteomics of differentially expressed proteins. a Protein lysates of WT-iAstro#2, #3, #5, #6 and 3Tg-iAstro#2, #3, #4, #6
were subjected to LC-MS/MS with consequent SWATH-MS (see details in Methods section). In total, 1119 and 1045 proteins were detected in WT-
and 3Tg-iAstro lines, respectively, among which 856 were expressed in both types of samples. The list of 1119 proteins common for all four WT-iAstro
lines was compared for presence of common entries with two astroglial proteomics datasets contributed by Hanreider et al.43 and Yang et al.44.
b Top 20 of up- and down-regulated proteins emerged from mass spectrometry proteomics
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second group (enrichment score 8.9) was composed of 5
proteins related to RNA binding and to the formation of
ribonucleoprotein complex (Supplementary Table 4A).
To explore functional significance of up-regulated vs
down-regulated proteins, we analyzed separately 23 up-
regulated and 50 down-regulated proteins. Analysis of
up-regulated proteins did not return significantly over-
represented GO terms, while functional annotation GO
analysis of the 50 down-regulated proteins returned
10 significantly overrepresented GO terms which were
related to RNA binding, ribonucleoprotein complex,
ribosome and nucleus (Table 2 and Supplementary
Table 4B).
We then used STRING (Search Tool for the Retrieval of
Interacting Genes/Proteins) database that allows predic-
tion of protein–protein interacting networks and clus-
tering. For this we used a list of 73 differentially expressed
proteins which included both down- and up-regulated
hits. As shown in Fig. 8, STRING software found sig-
nificantly more interactions than may be expected by
Table 1 Top 20 up- and down-regulated proteins in 3Tg-iAstro compared to WT-iAstro lines
Uniprot_ID Description Fold change P value
Top 20 of UP-regulated proteins
CALM_MOUSE Calmodulin OS=Mus musculus GN= Calm1 PE= 1 SV= 2 3.57 0.00067
ACTG_MOUSE Actin, cytoplasmic 2 OS=Mus musculus GN= Actg1 PE= 1 SV= 1 3.46 0.00229
EZRI_MOUSE Ezrin OS=Mus musculus GN= Ezr PE= 1 SV= 3 3.16 0.00189
PUR4_MOUSE Phosphoribosylformylglycinamidine synthase OS=Mus musculus GN= Pfas PE= 2 SV= 1 3.16 0.00287
ACTB_MOUSE Actin, cytoplasmic 1 OS=Mus musculus GN= Actb PE= 1 SV= 1 3.10 0.00358
MAOM_MOUSE NAD-dependent malic enzyme, mitochondrial OS=Mus musculus GN=Me2 PE= 2 SV= 1 2.86 0.01149
APMAP_MOUSE Adipocyte plasma membrane-associated protein OS=Mus musculus GN= Apmap PE= 1 SV= 1 2.66 0.04597
VDAC1_MOUSE Isoform Mt-VDAC1 of Voltage-dependent anion-selective channel protein 1 OS=Mus musculus GN= Vdac1 2.58 0.04867
MYH10_MOUSE Myosin-10 OS=Mus musculus GN=Myh10 PE= 1 SV= 2 2.35 0.01125
XPO1_MOUSE Exportin-1 OS=Mus musculus GN= Xpo1 PE= 1 SV= 1 2.16 0.01711
MYADM_MOUSE Myeloid-associated differentiation marker OS=Mus musculus GN=Myadm PE= 2 SV= 2 2.15 0.03671
MCA3_MOUSE Eukaryotic translation elongation factor 1 epsilon-1 OS=Mus musculus GN= Eef1e1 PE= 2 SV= 1 1.95 0.03302
KCRB_MOUSE Creatine kinase B-type OS=Mus musculus GN= Ckb PE= 1 SV= 1 1.80 0.04875
HMOX1_MOUSE Heme oxygenase 1 OS=Mus musculus GN= Hmox1 PE= 1 SV= 1 1.80 0.01236
FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus GN= Fermt2 PE= 1 SV= 1 1.80 0.02534
GLRX3_MOUSE Glutaredoxin-3 OS=Mus musculus GN= Glrx3 PE= 1 SV= 1 1.60 0.03293
ADT1_MOUSE ADP/ATP translocase 1 OS=Mus musculus GN= Slc25a4 PE= 1 SV= 4 1.58 0.00764
IF4H_MOUSE Eukaryotic translation initiation factor 4H OS=Mus musculus GN= Eif4h PE= 1 SV= 3 1.55 0.00594
IF5A1_MOUSE Eukaryotic translation initiation factor 5A-1 OS=Mus musculus GN= Eif5a PE= 1 SV= 2 1.50 0.03688
FSCN1_MOUSE Fascin OS=Mus musculus GN= Fscn1 PE= 1 SV= 4 1.47 0.02807
Top 20 of DOWN-regulated proteins
K2C1B_MOUSE Keratin, type II cytoskeletal 1b OS=Mus musculus GN= Krt77 PE= 1 SV= 1 −4.89 0.02491
RABP1_MOUSE Cellular retinoic acid-binding protein 1 OS=Mus musculus GN= Crabp1 PE= 1 SV= 2 −3.96 0.00811
RANG_MOUSE Ran-specific GTPase-activating protein OS=Mus musculus GN= Ranbp1 PE= 1 SV= 2 −3.15 0.000058
MYEF2_MOUSE Myelin expression factor 2 OS=Mus musculus GN=Myef2 PE= 1 SV= 1 −2.76 0.00512
RL5_MOUSE 60S ribosomal protein L5 OS=Mus musculus GN= Rpl5 PE= 1 SV= 3 −2.36 0.00058
RS30_MOUSE 40S ribosomal protein S30 OS=Mus musculus GN= Fau PE= 1 SV= 1 −2.33 0.01976
DDX17_MOUSE Probable ATP-dependent RNA helicase DDX17 OS=Mus musculus GN= Ddx17 PE= 1 SV= 1 −2.25 0.0443
KPYM_MOUSE Isoform M1 of pyruvate kinase PKM OS=Mus musculus GN= Pkm −2.21 0.01086
MIF_MOUSE Macrophage migration inhibitory factor OS=Mus musculus GN=Mif PE= 1 SV= 2 −2.13 0.04215
K22E_MOUSE Keratin, type II cytoskeletal 2 epidermal OS=Mus musculus GN= Krt2 PE= 1 SV= 1 −2.06 0.04617
ANXA6_MOUSE Annexin A6 OS=Mus musculus GN= Anxa6 PE= 1 SV= 3 −2.05 0.01972
S10A6_MOUSE Protein S100-A6 OS=Mus musculus GN= S100a6 PE= 1 SV= 3 −2.02 0.00021
BTF3_MOUSE Isoform 2 of transcription factor BTF3 OS=Mus musculus GN= Btf3 −2.02 0.00144
SARNP_MOUSE SAP domain-containing ribonucleoprotein OS=Mus musculus GN= Sarnp PE= 1 SV= 3 −2.01 0.03162
RL19_MOUSE 60S ribosomal protein L19 OS=Mus musculus GN= Rpl19 PE= 1 SV= 1 −1.92 0.0261
HNRPM_MOUSE Heterogeneous nuclear ribonucleoprotein M OS=Mus musculus GN= Hnrnpm PE= 1 SV= 3 −1.89 0.00045
ENPL_MOUSE Endoplasmin OS=Mus musculus GN= Hsp90b1 PE= 1 SV= 2 −1.85 0.01527
RS15_MOUSE 40S ribosomal protein S15 OS=Mus musculus GN= Rps15 PE= 2 SV= 2 −1.84 0.00744
RL13_MOUSE 60S ribosomal protein L13 OS=Mus musculus GN= Rpl13 PE= 2 SV= 3 −1.83 0.03011
EF1D_MOUSE Elongation factor 1-delta OS=Mus musculus GN= Eef1d PE= 1 SV= 3 −1.80 0.03256
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chance (p < 1.0e−16). To search for possible interacting
clusters we used STRING k-means clustering function
followed by GO analysis. Figure 8 shows three clusters
found by STRING. GO analysis revealed that cluster #1
(red in Fig. 8) returned two GO terms, myelin sheath and
extracellular exosome. Cluster #2 (green in Fig. 8)
returned 13 GO terms related to translation, ribosome
and RNA binding, while cluster #3 (blue in Fig. 8)
returned 15 GO terms related to nuclear ribonucleopro-
tein complex and splicing (Supplementary Table 5).
Altogether, this analysis suggests that in 3Tg-iAstro lines,
the protein synthesis machinery may be impaired.
Discussion
Here we report the generation and characterization of
novel immortalized astroglial lines from the hippocampus
of a common AD mouse model, 3xTg-AD mice45 and
from its WT counterpart. For immortalization, we used
transduction with SV40 large T antigen, a protocol that
has been extensively used previously14,46,47. During
exploitation of the protocol we did not proceed with
clonal selection, but instead continued growing and
expanding a population of transduced cells. This allowed
us to avoid the inter-clonal heterogeneity that is a char-
acteristic of clonal selection48–50. Validity of this approach
was efficiently demonstrated in gene expression and
proteomics analyses, in which four independently gener-
ated iAstro lines for both WT and 3Tg-AD genotypes
were analyzed and gave consistent results, and also
demonstrated that 3Tg-iAstro retains the differences as
compared with WT-iAstro found previously in primary
cultures40.
To validate our model we used a number of methods
including immunocytochemistry, real-time PCR
(RT-PCR), electrophysiology and Ca2+ measurements.
We show that the WT-iAstro cell lines express the
astrocytic markers AQP4, GS and Aldh1l1, although at
lower levels compared to primary cells and have electro-
physiological properties comparable to primary astro-
cytes, at least as determined by evaluation of the Kir
current. Similarly, real-time PCR of selected genes as well
as mass spectrometry for proteins shows that the
expression profile is similar to primary astrocytes. For a
quantitative estimation of the astrocytic phenotype of
iAstro lines, we have compared our proteomics data with
similar data obtained on primary astroglial cultures. For
this we used two lists reporting data from primary cul-
tured rat43 and mouse44 cortical astrocytes. When our list
was compared with the above-mentioned datasets, rela-
tively high percentage of common proteins was found
(65% of those reported by Hanrieder et al.43 and 74% of
those reported by Yang et al.44), indicating that our list
efficiently covers both analyzed datasets. This further
confirms that after immortalization procedure, iAstro
retains an astroglial phenotype. The only difference of
note observed was a small proportion of GFAP-positive
cells.
Having established that iAstro cell lines replicate pri-
mary culture, we next evaluated whether the changes
observed in AD models could be replicated by the 3xTg-
iAstro cells. For this, we capitalized on our previous data
on Ca2+ signaling and on transcriptional profiling.
Deregulations of astroglial Ca2+ signaling in AD have
been reported30,51–53. Our group has demonstrated that
primary hippocampal astrocytes from 3xTg-AD mice
exhibit enhanced ATP-induced Ca2+ signals34 and
SOCE39. In line with results on primary cultures, 3Tg-
iAstro exhibited significantly higher amplitude of Ca2+
signals in response to ATP stimulation which is accom-
panied by enhanced SOCE. Analyzing components of the
purinergic Ca2+ signaling we noticed that P2ry2 ATP-
sensitive receptor is significantly up-regulated in both
Table 2 Over-represented GO terms
GO category GO term Count Fold enrichment Benjamini
GOTERM_CC_DIRECT GO:0030529~intracellular ribonucleoprotein complex 17 3.30 0.0013
GOTERM_CC_DIRECT GO:0005840~ribosome 12 3.96 0.0051
GOTERM_CC_DIRECT GO:0005634~nucleus 37 1.51 0.0121
GOTERM_CC_DIRECT GO:0022625~cytosolic large ribosomal subunit 8 4.42 0.0391
GOTERM_MF_DIRECT GO:0044822~poly(A) RNA binding 31 2.25 0.0001
GOTERM_MF_DIRECT GO:0003735~structural constituent of ribosome 12 3.54 0.0191
GOTERM_MF_DIRECT GO:0003723~RNA binding 16 2.37 0.0577
KEGG_PATHWAY mmu03010:Ribosome 12 3.56 0.0065
UP_KEYWORDS Ribonucleoprotein 15 3.03 0.0074
UP_KEYWORDS Ribosomal protein 12 3.77 0.0146
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primary 3Tg astrocytes40 and in 3Tg-iAstro lines, corro-
borating the Ca2+ imaging data presented in Fig. 4.
Notably, none of iAstro lines responded to DHPG or
glutamate (not shown), suggesting that function or/and
expression of mGluR5 may be hampered by the immor-
talization process.
We used the iAstro model for proteomics to demon-
strate its usefulness and to add information on the role of
astrocytes in AD. GO analysis of proteins down-regulated
in 3Tg-iAstro as compared to WT-iAstro lines suggests
that translation may be impaired in 3Tg-iAstro lines in
two manners: (1) formation of nuclear ribonucleoprotein
complex; and (2) formation of ribosomal multi-protein
complex. Protein synthesis has already been suggested to
be impaired in AD54–56 and recent findings suggest that it
may occur early in AD pathogenesis57. In AD hippocampi,
down-regulation of several proteins involved in chromatin
compacting and regulation of rRNA transcription has
been reported58 including nucleolin, which is also present
in our list. Ribosomes are composed of the ribosomal
RNAs and the ribosomal proteins that form the small
subunit (40S) which binds to mRNA and the large subunit
(60S) which binds to transfer RNAs and amino acids.
Small subunit contains 33 proteins of which 3 (9%) are
present in our list of down-regulated proteins, while large
subunit contains 46 proteins of which 8 (17.3%) are pre-
sent in our list, altogether suggesting that alterations in
translation may represent an early astrocyte-specific event
in AD pathogenesis57. Finally, we acknowledge that the
straightforward translation of the results obtained on
Fig. 8 Analysis of possible protein–protein interaction network using STRING tool. List of differentially expressed proteins was subjected to
STRING analysis which found significantly more associations between proteins that would have occurred by chance (p= 1.0e−16). Three clusters
detected by k-means algorithm are colored as follows: cluster 1 (46 proteins, red), proteins related to myelin sheet and extracellular exosomes; cluster
2 (19 proteins, green), proteins related to translation and ribosome; cluster 3 (8 proteins, blue), proteins related to nuclear ribonucleoprotein complex
and splicing. For related lists of proteins see also Supplementary Table 5
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immortalized astrocytes in in vitro experiments to human
AD pathogenesis is a rather speculative over-
simplification. Further experiments, aiming at investigat-
ing the mechanistic aspects and confirmation of these
results in vivo, are necessary to validate the presented
data.
Transcriptome analysis of astrocytes freshly isolated
from the brain of APPswe/PS1d9ex AD model mice at a
symptomatic stage59, as well as of hippocampal cultured
astrocytes from 3xTg-AD mice40, shows significant
enrichment of genes in GO terms related to Ca2+.
Proteomics data, however, do not reveal an over-
representation of GO terms related to Ca2+. This may,
at least in part, be explained by the fact that the shotgun
mass spectrometry, used in this work, allows detection
of only the most abundant proteins in iAstro lines. None
of the proteins of the classical Ca2+ signaling toolkit,
like Ca2+ transporters, channels or receptors, including
P2Y2 purinergic receptor, has been detected. It is worth
noting that the highest up-regulated protein in our
analysis is calmodulin (CaM) (Table 1), whose role is to
sense fluctuation of Ca2+ concentrations60,61. Down-
stream events include either transmission of the infor-
mation to Ca2+-regulated signaling hubs, like Ca2
+/CaM-activated kinases (CaMKs) of phosphatase cal-
cineurin, or direct modulation of the activity of proteins,
e.g., plasma membrane Ca2+ ATPase. Therefore, it is
reasonable to suggest that 3.6-fold CaM overexpression
in 3Tg-iAstro as compared to WT-iAstro (Table 1) may
alter the entire Ca2+-dependent cellular homeostasis.
While characterization of CaM-dependent processes in
iAstro lines lies beyond the scope of present work, it is
worth noting that in AD-related research, CaM-
activated enzymes like CaMKII or calcineurin have
been recurrently mentioned as central elements of dis-
ease pathogenesis and represent possible pharmacolo-
gical targets41,62,63. Last, it has been recently suggested
that CaM binds with high affinity to Aβ, thus repre-
senting a direct target for toxic Aβ peptide64. In light of
our observations, our data warrant further detailed
examination of the role of CaM in AD.
In conclusion, we have immortalized and characterized
hippocampal astrocytes from WT and 3xTg-AD mouse
pups. Using complementary methodologies we show that
iAstro lines retain astroglial pattern of protein expression,
retain fundamental astroglial housekeeping functions and
show transcriptional and functional alterations found
previously in primary astrocytes from 3xTg-AD mice
compared to WT mice. In addition, proteomic analysis
suggests that protein synthesis, due to impaired nuclear
RNA binding and alterations in ribosome composition,
may be specifically impaired in AD astrocytes. Altogether,
our results suggest that 3Tg-iAstro may be a useful tool to
study astrocyte-related alterations in AD.
Materials and methods
Animals
3xTg-AD mice used in this work were introduced by
Frank LaFerla, Salvatore Oddo and colleagues in 200345.
These mice were developed on the mixed 129/C57BL6
background bearing knock-in mutation PS1M146V
65 and in
which APPswe and TauP301L transgenes were introduced.
The 3xTg-AD animals show major histological hallmarks
of AD represented by senile plaques and neurofibrillary
tangles. These mice show progressive learning and
memory deficit beginning from 4 months of age66. The
3xTg-AD mice and their respective non-transgenic con-
trols (WT)45 were housed in the animal facility of the
Università del Piemonte Orientale, were kept at three to
four per cage and had unlimited access to water and food.
Animals were managed in accordance with the European
directive 2010/63/UE and with Italian law D.l. 26/2014.
The procedures were approved by the local animal-health
and ethical committee (Università del Piemonte Orien-
tale) and were authorized by the national authority (Isti-
tuto Superiore di Sanità; authorization number N. 22/
2013). All efforts were made to reduce the number of
animals by following the 3R (replacement, reduction and
refinement) rule.
Primary astroglial cultures preparation and astrocyte
purification
For primary astroglial cultures, WT and 3xTg-AD P0-
P2 pups were killed by decapitation. Hippocampi were
rapidly dissected and minced with a scalpel blade in cold
calcium- and magnesium-free Hank’s Balance Salt Solu-
tion (Sigma-Aldrich). The tissues were then digested with
trypsin (Sigma-Aldrich; 0.25%, 37 °C) and triturated with
30 strokes of an automatic pipette. Non-dissociated tissue
was allowed to sediment for 2 min and cell suspension
was centrifuged for 5 min (200 × g), resuspended in
complete culture medium (Dulbecco’s modified Eagle’s
medium (DMEM; Sigma-Aldrich, Cat. No. D5671) sup-
plemented with 10% fetal bovine serum (Gibco, Cat. No.
10270), 2 mM L-glutamine (Sigma-Aldrich), and 1%
penicillin/streptomycin solution (Sigma-Aldrich) and
plated in 60mm Petri dishes (Falcon) (hippocampi from
3–6 pups per dish). Cells were maintained in a 5% CO2 37
°C incubator. At ~90% of confluence, cells were detached
and microglial cells were removed by MACS using anti-
CD11b-conjugated beads (Miltenyi Biotech, Cat. No. 130-
093-634). Purified astrocytes were collected, resuspended
in complete culture medium and plated in a 35mm dish
for immortalization.
Production of SV40-containing replication-defective
retroviral vectors
Phoenix cells producing a replication-defective retro-
virus67, grown in 100 mm culture dishes (Falcon, 1.5 × 106
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cells per dish), were transfected with pBABE-neo encod-
ing neomycin phosphotransferase and SV40 large T
antigen (Addgene, plasmid ID 178068), using Lipofecta-
mine 2000 reagent (Life Technologies, Segrate, Italy),
according to the manufacturer’s instructions. At 48 h after
transfection, cell medium containing the retroviral vectors
was collected and filtered through 0.4 μm filters. The
retroviral particles were precipitated by polyethylene
glycol (O/N, 4 °C) prepared as described elsewhere69.
The precipitate was concentrated by centrifugation
(3500 × g, 30 min, 4 °C), the supernatant was discarded
and the pellet was resuspended in complete culture
medium (200 μl per 8 ml of initial medium), divided in
100 μl aliquots and stored at −80 °C.
Astrocyte immortalization
MACS-purified hippocampal astrocytes were plated in
35mm culture dishes (2.5 × 105 cells per dish) and 24 h
later were transduced with retrovirus expressing SV40
large T antigen. To increase the infection efficiency,
dishes were shaken (80 rpm) overnight in a cell incubator.
After 24 h, fresh medium was added for 72 h and then
replaced with medium containing 0.4 mg/ml G418 dis-
ulfate salt solution (Sigma-Aldrich)70. At 3 to 4 weeks
after cell selection, surviving cells were first sub-cultured
in 100mm dishes, expanded and maintained in complete
culture medium supplemented with 0.4 mg/ml G418 until
passage 10. After thawing from cryopreservation, iAstro
lines were maintained in complete culture medium
without G418 and used for experiments between passages
12 and 20.
Immunofluorescence
WT- and 3Tg-iAstro cells, grown on 13 mm glass cov-
erslips, were fixed in 4% formaldehyde, permeabilized (7
min in 0.1% Triton X-100 in phosphate-buffered saline
(PBS)) and immunoprobed with an appropriate primary
antibody (diluted in PBS supplemented with 1% gelatin)
for 1 h at 37 °C. After 3 times washing in PBS, an Alexa-
conjugated secondary antibody (1:300 in PBS supple-
mented with 1% gelatin) was applied for 1 h at room
temperature (RT). The following primary antibodies were
used: AQP4 (Alomone Labs, Cat. No. 249-323), Aldh1l1
(Abcam, Cat. No. Ab190298), GS (Abcam, Cat. No.
Ab73593), GFAP (Chemicon International, Cat. No.
CBL411) and GLT-1 (Alomone labs, Cat. No. AGC-022).
Secondary antibodies were as follows: Alexa Fluor 488
anti-mouse IgG, Alexa Fluor 555 anti-rabbit IgG (all
secondary antibodies were from Molecular Probes, Life
Technologies, Monza, Italy). Nuclei were counter-stained
with 4′,6-diamidino-2-phenylindole (DAPI). Images were
acquired by Zeiss 710 confocal laser scanning microscope
equipped with EC Plan-Neofluar 40×/1.30 Oil DIC M27
objective and Zen software.
Total RNA extraction and real-time PCR
Total RNA was extracted from 1 × 106 cells using
Absolutely RNA miRNA kit (Agilent, Santa Clara, CA)
according to the manufacturer’s instructions. Total RNA
(0.5–1 μg) was retro-transcribed using random hexamers
and ImProm-II RT system (Promega, Milan, Italy). Real-
time PCR was performed using iTaq qPCR master mix
according to the manufacturer’s instructions (Bio-Rad,
Segrate, Italy) on a SFX96 Real-time system (Bio-Rad). To
normalize raw real-time PCR data, S18 ribosomal subunit
was used. Sequences of oligonucleotide primers are pro-
vided in Supplementary Materials. The real-time PCR
data are expressed as delta-C(t) of gene of interest to S18
allowing appreciation of the relative expression level of a
single gene.
Electrophysiological recordings
To perform patch-clamp experiments in whole-cell
configuration, both WT-iAstro and 3Tg-iAstro were
plated separately in 35 mm dishes 24 h prior experiments.
Cells were plated at low density to allow recordings from
isolated astrocytes. They were transferred from culture
medium to an extracellular solution containing (in mM):
138 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 glucose and 10
HEPES at pH 7.25 adjusted with NaOH. Borosilicate
patch pipettes were pulled with a P-1000 puller (Sutter
Instruments, USA) and were filled with a solution con-
taining (in mM): 140 KCl, 2 NaCl, 5 EGTA, 0.5 CaCl2 and
10 HEPES at pH 7.25 adjusted with KOH. Pipette tip
resistance containing this solution was between 3 and 5
MΩ. Experiments were performed using an EPC7 Plus
amplifier (HEKA Elektronik, Germany) in voltage-clamp
configuration (holding potential, –80mV). Access resis-
tance (8–12MΩ) was compensated (80–90%) and
experiments were performed at RT and in a static bath.
Data were acquired at 5 kHz and filtered at 1 kHz using a
7-pole Bessel filter and digitized with a low noise data
acquisition system, Digidata 1440A (Molecular Devices,
USA). Data were recorded and analyzed in pClamp 10
(Molecular Devices, Crisel Instruments, Italy). Data were
initially processed with Microsoft Excel. Plots, bar dia-
grams and figure preparations were finalized with
GraphPad Prism (GraphPad Software, La Jolla, CA).
Cell lysates
WT- and 3Tg-iAstro cells were plated at a density of 2 ×
105 cells/100mm dish and cultured until 80–90% of con-
fluence. Then, cells were washed twice with cold PBS and
lysed in 800 µl lysis buffer (50mM Tris-HCl pH 7.4, 150
mM NaCl, 0,5mM EDTA, 0,1% NP40, 0,1% SDS) supple-
mented with protease and phosphatase inhibitors cocktail
(Thermo Scientific Halt Protease and Phosphatase Inhibitor
Cocktail, Cat. No. 78444). For each sample, protein con-
centration was measured by BCA assay (Quanti Pro BCA
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Asssay Kit, SIGMA, Cat. No. QPBCA-1Kt) and read by Bio-
Rad SMARTTMPlus Spectrophotometer.
Western blotting
Specific astroglial proteins were detected in WT- and
3Tg-iAstro lysates by western blotting (WB). Each sample,
containing 100 µg of protein, was diluted 1:1 in 2×
Laemmli sample buffer, heated at 95 °C for 5 min, then
resolved by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE). Proteins were electro-
phoretically transferred to nitrocellulose membranes and
the membranes were blocked for 1 h in 5% (w/v) non-fat
dry milk in Tris-buffered saline containing Tween-20.
After incubation with appropriate primary and secondary
antibodies, signals were revealed using enhanced chemi-
luminescence (Super Signal West Femto Maximum Sen-
sitivity Substrate, Thermo Scientific, Cat. No. 34095), and
were visualized by a Bio-Rad ChemiDoc touch Imaging
system. Anti-AQP4 (1:1000, Alomone Labs, Cat. 249-
323), anti-GS (1:2000, Abcam, Cat. No. Ab73593), anti-
Aldh1l1 (1:2000, Abcam, Cat. No. Ab190298) and anti-β-
actin (1:10,000, Sigma, Cat. No. A1978) antibodies were
used to develop western blots, as indicated in the figure
legends. Densitometric analysis was performed using
Quantity One software and is expressed as mean ± SEM
from at least 3 independent runs. Analysis of variance
(ANOVA) test was used for statistical analysis. Note
relatively big variability between technical replicates in
WB analysis, which may be explained by low level of
specific astroglial proteins expressed in iAstro lines.
Fura-2 calcium imaging
For Ca2+ imaging, iAstro lines grown onto 24mm
round coverslips were loaded with Fura-2/AM (Life
Technologies, Milan, Italy, Cat. No. F1201) in the pre-
sence of 0.005% Pluronic F-127 (Life Technologies, Cat.
No. P6867) and 10 μM sulfinpyrazone (Sigma, Cat. No.
S9509) in KRB solution (125 mM NaCl, 5 mM KCl, 1 mM
Na3PO4, 1 mM MgSO4, 5.5 mM glucose, 20 mM HEPES,
pH 7.4) supplemented with 2 mM CaCl2. After loading
and 30 min of de-esterification, the coverslips were
mounted in an acquisition chamber on the stage of a Leica
epifluorescence microscope equipped with a S Fluor 40×/
1.3 objective. Cells were alternatively excited at 340/380
nm by the monochromator Polichrome V (Till Photonics,
Munich, Germany) and the fluorescent signal was col-
lected by a CCD camera (Hamamatsu, Japan) through
bandpass 510 nm filter; the experiments were controlled
and images analyzed with MetaFluor (Molecular Devices,
Sunnyvale, CA, USA) software. The cells were stimulated
by 20 μM ATP. To quantify the difference in the ampli-
tude of Ca2+ transients, the ratio values were normalized




Cell lysates were digested using the following protocol:
samples were prepared to have 100 μg of protein in a final
volume of 25 μl of 100mM NH4HCO3. Proteins were
reduced using 2.5 μl of dithiothreitol (200 mM DTT stock
solution) (Sigma) at 90 °C for 20min, and alkylated with
10 μl of Cysteine Blocking Reagent (iodoacetamide (IAM),
200mM Sigma) for 1 h at room temperature in the dark.
DTT stock solution was then added to destroy the excess
of IAM. After dilution with 300 μl of water and 100 μl of
NH4HCO3 to raise pH 7.5–8.0, 5 μg of trypsin (Promega,
Sequence Grade) was added and digestion was performed
overnight at 37 °C. Trypsin activity was stopped by adding
2 μl of neat formic acid and samples were dried by Speed
Vacuum71.
The peptide digests were desalted on the Discovery®
DSC-18 solid-phase extraction (SPE) 96-well Plate (25
mg/well) (Sigma-Aldrich Inc., St. Louis, MO, USA). The
SPE plate was preconditioned with 1ml of acetonitrile
and 2ml of water. After the sample loading, the SPE was
washed with 1ml of water. The adsorbed proteins were
eluted with 800 μl of acetonitrile/water (80:20). After
desalting, samples were vacuum evaporated and recon-
stituted with 20 μl of 0.05% formic acid in water. Then, 2
μl of stable-isotope-labeled peptide standard
(DPEVRPTSAVAA, Val- 13C5 15N1 at V10, Cellmano
Biotech Limited, Anhui, China) was spiked into the
samples before the liquid chromatography–tandem mass
spectrometry (LC-MS/MS) analysis and used for instru-
ment quality control.
Label-free proteomic analysis
LC-MS/MS analyses were performed using a micro-LC
Eksigent Technologies (Dublin, USA) system with a sta-
tionary phase of a Halo Fused C18 column (0.5 × 100mm,
2.7 μm; Eksigent Technologies, Dublin, USA). The injec-
tion volume was 4.0 μl and the oven temperature was set
at 40 °C. The mobile phase was a mixture of 0.1% (v/v)
formic acid in water (A) and 0.1% (v/v) formic acid in
acetonitrile (B), eluting at a flow rate of 15.0 μl/min at an
increasing concentration of solvent B from 2 to 40% in 30
min. The LC system was interfaced with a 5600+Triple-
TOF system (AB Sciex, Concord, Canada) equipped with
a DuoSpray Ion Source and CDS (Calibrant Delivery
System). Samples used to generate the SWATH-MS
(sequential window acquisition of all theoretical mass
spectra) spectral library were subjected to the traditional
data-dependent acquisition (DDA): the mass spectro-
meter analysis was performed using a mass range of
100–1500 Da (TOF scan with an accumulation time of
0.25 s), followed by a MS/MS product ion scan from 200
to 1250 Da (accumulation time of 5.0 ms) with the
abundance threshold set at 30 cps (35 candidate ions can
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be monitored during every cycle). Samples were then
subjected to cyclic data-independent analysis (DIA) of the
mass spectra, using a 25 Da window. A 50ms survey scan
(TOF-MS) was performed, followed by MS/MS experi-
ments on all precursors. These MS/MS experiments were
performed in a cyclic manner using an accumulation time
of 40 ms per 25 Da swath (36 swaths in total) for a total
cycle time of 1.5408 s. The ions were fragmented for each
MS/MS experiment in the collision cell using the rolling
collision energy. The MS data were acquired with Analyst
TF 1.7 (SCIEX, Concord, Canada). Three instrumental
replicates for each sample were subjected to the DIA
analysis72,73.
Protein database search
The mass spectrometry files were searched using Pro-
tein Pilot (AB SCIEX, Concord, Canada) and Mascot
(Matrix Science Inc., Boston, USA). Samples were input in
the Protein Pilot software v. 4.2 (AB SCIEX, Concord,
Canada), which employs the Paragon algorithm, with the
following parameters: cysteine alkylation, digestion by
trypsin, no special factors and false discovery rate (FDR) at
1%. The UniProt Swiss-Prot reviewed database containing
mouse proteins (version 20july15, containing
23,304 sequence entries). The Mascot search was per-
formed on Mascot v. 2.4, the digestion enzyme selected
was trypsin, with 2 missed cleavages and a search toler-
ance of 50 ppm was specified for the peptide mass toler-
ance, and 0.1 Da for the MS/MS tolerance. The charges of
the peptides to search for were set to 2+, 3+ and 4+, and
the search was set on monoisotopic mass. The instrument
was set to ESI-QUAD-TOF (electrospray ionization
quadrupole time-of-flight) and the following modifica-
tions were specified for the search: carbamidomethyl
cysteines as fixed modification and oxidized methionine
as variable modification.
Protein quantification
The quantification was performed by integrating the
extracted ion chromatogram of all the unique ions for a
given peptide. The quantification was carried out with
PeakView 2.0 and MarkerView 1.2. (Sciex, Concord, ON,
Canada). Six peptides per protein and six transitions per
peptide were extracted from the SWATH files. Shared
peptides were excluded as well as peptides with mod-
ifications. Peptides with FDR lower than 1.0% were
exported in MarkerView for the t-test.
Analysis of identified proteins
For identification of the number of detected proteins for
each genotype, the intersection of four lists, correspond-
ing to four analyzed lines per genotype, was performed,
yielding lists of common proteins detected in four WT-
and four 3Tg-iAstro lines (1119 and 1045, respectively).
The intersection of the latter two lists gave proteins
detected in both WT- and 3Tg-iAstro cells (856 proteins).
Gene ontology analysis
GO analysis was performed using DAVID v.6.8 tool
(https://david.ncifcrf.gov/)74. For the analysis of the
overrepresented GO terms, for the background, a list
containing all proteins detected in WT-iAstro and 3Tg-
iAstro lines (1308 proteins) was used. Over-represented
GO terms which passed Benjamini correction (p < 0.05)
were considered significant. For prediction of
protein–protein interactions and clustering using k-
means algorithm, STRING v.10.5 online software was
used (https://string-db.org/)75.
Glutamate uptake
Primary astrocytes, WT and 3Tg-iAstro lines were
cultured in 24-well plates at 5 × 104 cells /well. Cells were
treated in DMEM/F12 medium with 5mM glutamate (L-
glutammic acid momosodium salt, Sigma, Cat. No.
G1626) with or without TBOA ((3S)-3-[[3-[[4-(tri-
fluoromethyl)bemzoyl]amino]phenyl]methoxy]-L-aspartic
acid, Tocris, Cat. No. 2532). After 2 h, supernatants were
collected, centrifuged (16,000 × g for 10 min at 4 °C) and
analyzed for residual glutamate using the protocol
described by the manufacturers (Amplex® Red Glutamic
Acid/Glutamate Oxidase Kit, Invitrogen, Cat. No.
A12221). Glutamate uptake was calculated as difference
of fluorescence at 590 nm between glutamate plus TBOA
and glutamate alone and normalized to protein con-
centrations of corresponding cell lysate.
LPS and TNFα treatment
For treatment with bacterial LPS (lipopolysaccharides
from Escherichia coli O111:B4, Sigma, Cat. No. L2630)
and TNFα (Peprotech, London, UK, Cat. No. 300-01A),
cells were plated in 12-well plates (1 × 105 cells per well)
and, upon confluence, were treated with either LPS (for 3
h) or TNFα (for 6 h). The cells were then lysed in 500 μl
Trizol Reagent (Life Technologies) and total RNA was
extracted according to the manufacturer’s instructions.
First-strand complementary DNA and real-time PCR
were performed as described above. Oligonucleotide pri-
mers for iNOS are listed in Supplementary Materials.
Experimental groups selection and statistical analysis
For the selection of experimental groups, the following
criteria were adopted: in experiments in which entire
populations of cells were analyzed (western blotting, real-
time PCR and proteomic analysis), experimental group
was composed of 4 independently generated iAstro lines
for each genotype (WT-iAstro#2, #3, #5 and #6, and 3Tg-
iAstro#2, #3, #4 and #6) representing biological replicates.
Technical replicates consisted of at least three
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independent experiments of each iAstro line. In experi-
ments, in which single-cell analysis was performed
(immunocytochemistry, electrophysiology and Fura-2 Ca2
+ imaging), experimental groups were composed of
independent experiments (at least three coverslip (tech-
nical replicates) from at least three different experiments)
of one line per genotype were used (WT-iAstro#2 and
3Tg-iAstro#2).
Statistical analysis was performed using GraphPad
Prism software v.7. For analysis of real-time PCR and
Ca2+ imaging data, a two-tailed unpaired Students’s t-test
was used. For western blot ANOVA on raw followed by
Tukey’s post-hoc test was used. Differences were con-
sidered significant at p < 0.05.
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